The cheapest way to get a GLP-1, priced route by route
Evidence-sourced
Written and fact-checked to our published editorial standards.Last updated 2026-08-04. Every clinical claim on this page is sourced to a named primary authority, listed at the foot of the page — see how we research, source, and correct our work.
No affiliate links, referral fees, or paid placements
Every price traced to the company that published it
Prices checked 2026-07-26
Nothing here is ranked “best”
The short answer
The cheapest GLP-1 is decided by who is paying, not by which drug you pick. With commercial insurance that covers it, a manufacturer savings card takes it to as little as $25 a month. On Medicare, the GLP-1 Bridge programme is a flat $50 a month for eligible Part D enrollees. Paying cash, the lowest published price for an FDA-approved product is $149 a month for Wegovy tablets bought direct from the manufacturer.
That last figure is the one most “cheapest GLP-1” lists miss. It is lower than the cheapest compounded telehealth total we could derive from published prices — about $178 a month at Mochi Health, once the membership is added to the medication. And there is no over-the-counter GLP-1 at any price.
What is the cheapest GLP-1 for you?
“Cheapest” is decided by who is paying, not by which drug you pick. Tell us two things and we’ll show the routes open to you in published-price order, then the telehealth providers priced the way you’ll actually be billed — membership and medication added together, with every figure traced to what the company itself publishes.
Cheapest published route open to you
Buy direct from the manufacturer, self-pay
$149per month, from
Who you pay
Novo Nordisk (NovoCare Pharmacy) or Eli Lilly (LillyDirect)
What that buys
The medication, shipped. No membership, no subscription, no coaching.
The catch
You still need a prescription, and getting one costs whatever your prescriber charges — nothing extra if you already see a doctor, a visit fee if you don't. The self-pay price also varies by dose, so a figure quoted at the starting dose may not be what you pay at the maintenance dose.
How that figure is published: NovoCare self-pay: Wegovy tablets from $149/month, injection pens from $299/month, Ozempic from $349/month. Lilly self-pay: Zepbound KwikPen $299–$449/month by dose, Mounjaro $499/month. NovoCare (Novo Nordisk), checked 2026-07-25.
Your other routes, in price order
A telehealth membership plus a compounded medication$178/mo
Compounded semaglutide and tirzepatide are not FDA-approved products, the supply channel is narrowing under a pending FDA proposal, and several providers in this group are in active litigation over how they marketed these products.
A telehealth membership plus a brand-name medication$223/mo
The membership buys access to a prescriber, not a lower drug price — the medication is charged on top, and the headline membership figure is usually the annual-prepay rate rather than the month-to-month one.
Online GLP-1 providers, priced the way you’re billed
Sorted by the lowest monthly total we could derive — a sort on the one thing you asked about, not a ranking of quality. Options we can price in full come first; the ones where a provider does not publish a component follow, because a floor is not a total. We have not used any of these services and do not rate them.
Priced in full — every component published
Mochi HealthMembership plus a 4-week supply of compounded semaglutide
$178/month
Membership
$79$79/month standard membership; an introductory $39 first month in eligible states.
Medication
$99Compounded semaglutide advertised around $99 for a 4-week supply, plus membership.
Priced per 4-week supply, so a year needs 13 of them, not 12
Named as a defendant in active Eli Lilly litigation
CalibrateThe 12-month metabolic programme, medication not covered by insurance
$325/month
Programme fee, spread over 12 months
$125Roughly $1,500–$1,800 for the 12-month programme fee. $125/month is the low end of that range divided by twelve — our arithmetic, not a monthly price Calibrate publishes.
Medication
$200Typically $200–$400/month if not covered by insurance; around $25/month copay for insured members after deductible.
Lowest rate requires $1,500 upfront.
Annual commitment
Programme fee is charged for the year, not monthly
$0No forced membership. An optional 'Success by Sesame' subscription starts at $59/month.
Programme or visit
$129Visits and GLP-1 programmes advertised from roughly $129/month.
Medication
not publishedWegovy is advertised from $199/month on some listings, but what any given listing includes is set by the individual clinician, so there is no platform-wide medication price to add.
This is a floor, not a total — medication is not published, so your real cost is higher than the figure shown.
Price is set by the individual clinician, not the platform
Whether a listing is brand or compounded varies by clinician
not publishedA One Medical membership is required for the full programme; the programme announcement we checked does not publish that fee as a figure. On-demand renewals for an existing prescription are published at $29 (message) or $49 (video).
Medication
$149$149/month oral and $299/month injectable, cash-pay. $25/month with insurance.
This is a floor, not a total — membership is not published, so your real cost is higher than the figure shown.
Fella HealthCompounded semaglutide on an annual plan
Not published
Membership
$199$199–$449/month depending on plan, including coaching.
Medication
not publishedCompounded semaglutide from $99/month, paid annually at $1,188.
Fella Health publishes a $199–$449/month membership that includes coaching, and separately advertises compounded semaglutide from $99/month on a $1,188 annual prepay. Its published figures do not say whether the medication price sits inside the membership or on top of it, so there is no monthly total here we would stand behind.
Lowest rate requires $1,188 upfront.
$99/month requires $1,188 upfront
Named as a defendant in active Eli Lilly litigation
not publishedNot published in a single, stable price list.
Medication
not publishedNot published in a single, stable price list.
Willow Health does not publish a stable price list, so there is nothing here to total. A provider that will not tell you the price before you sign up is itself a finding.
Lilly's case against Willow Health was dismissed in September 2025
We take no payment, referral fee, or free access from any provider here, so nothing on this page is placed or ordered by who pays us — see How We’re Funded. Every provider figure is that provider’s own published wording, checked 2026-07-26; the totals are our arithmetic on those figures and are shown beside the wording they came from. Prices in this category change constantly — confirm at checkout before you pay.
The five routes, priced
People search for the cheapest GLP-1 as though it were a property of the drug. It isn’t. The same medication, the same dose, the same week, costs $25 or $499 depending entirely on which of five routes you are eligible for — and the biggest savings come from moving between routes, not from haggling within one.
Each route ends with the same medication in your hand. What differs is who takes your money along the way, and how many of them there are.Figures as published by each organisation, checked 2026-07-26. Telehealth figures are our arithmetic on published membership and medication prices.
The routes to a GLP-1, cheapest published figure first. Telehealth totals are our own arithmetic on each company’s published membership and medication prices, not a price any company advertises as a single number.
Routeand who you pay
Fromper month
The catch
Your plan covers it, plus the manufacturer's savings cardYour pharmacy, at a copay
$25
It only works if your plan covers the drug at all, and a large share of employer plans exclude weight-management medications as a category. The card also caps what it pays, so a high copay is only partly offset.
The Medicare GLP-1 BridgeYour Part D plan's pharmacy
$50
Plan participation is voluntary, so yours may not take part. The formulation matters — Zepbound single-dose pens and vials are excluded — and the $50 counts toward neither your deductible nor your out-of-pocket cap.
Buy direct from the manufacturer, self-payNovo Nordisk (NovoCare Pharmacy) or Eli Lilly (LillyDirect)
$149
You still need a prescription, and getting one costs whatever your prescriber charges — nothing extra if you already see a doctor, a visit fee if you don't. The self-pay price also varies by dose, so a figure quoted at the starting dose may not be what you pay at the maintenance dose.
A telehealth membership plus a brand-name medicationThe telehealth company, then usually the pharmacy
$223
The membership buys access to a prescriber, not a lower drug price — the medication is charged on top, and the headline membership figure is usually the annual-prepay rate rather than the month-to-month one.
A telehealth membership plus a compounded medicationThe telehealth company, which uses a compounding pharmacy
$178
Compounded semaglutide and tirzepatide are not FDA-approved products, the supply channel is narrowing under a pending FDA proposal, and several providers in this group are in active litigation over how they marketed these products.
Over-the-counter, 'research' peptides, and GLP-1 supplementsNobody you can hold responsible
—
This is the one place on this page where the cheap price is the warning. Products sold without a prescription are outside the regulated supply chain, and 'research chemical' peptides are explicitly not intended for human use.
Two of those five are closed to most people the moment they read them: the savings card requires commercial insurance that covers the drug, and the Bridge requires Medicare Part D. That is not a technicality. It is the single biggest determinant of what you will pay, which is why the tool above asks about insurance before it asks about anything else.
The cheapest GLP-1 without insurance
This is the question behind most searches in this category, and the answer has changed. For two years the reflexive answer was “compounded semaglutide from a telehealth subscription”. On published prices, that is no longer true.
The cheapest published route to an FDA-approved GLP-1, for someone paying cash, is a tablet bought straight from the manufacturer — and it undercuts every compounded subscription total we were able to derive.
Manufacturer self-pay prices per month, verified 25 July 2026 against NovoCare and Eli Lilly. Self-pay prices vary by dose and by introductory offer. Confirm current pricing before you buy.
Product
Self-pay, directfrom the manufacturer
Form
Wegovy tablets
From $149
Daily tablet
Wegovy pens
From $299
Weekly injection
Zepbound KwikPen
$299–$449 by dose
Weekly injection
Ozempic
From $349
Weekly injection
Mounjaro
$499
Weekly injection
Foundayo (orforglipron)
Not published
Daily tablet
Three things about that table are worth saying plainly, because they are what turn it into a decision:
The tablet is the cheap one. At $149 a month, Wegovy tablets are the lowest published self-pay price for any FDA-approved product in this class — half the price of the same drug in a pen. If cost is the constraint, that is the conversation to have with your prescriber.
Buying direct still needs a prescription. Self-pay pricing is not the same as no-prescription. If you already see a doctor, getting one may cost you nothing extra; if you don’t, add whatever a visit costs — one directory provider publishes $129 for a visit without insurance, which is the kind of figure to budget against.
Not every price is published. Eli Lilly had not published a self-pay price for Foundayo as of 25 July 2026. We have left that cell empty rather than estimating it, and we would rather the gap be visible than filled.
The cheapest GLP-1 with insurance
If your plan covers the medication, nothing on this page beats it. Both manufacturers advertise as little as $25 a month for people with commercial insurance using the savings card. Two caveats decide whether that figure is real for you:
Your plan has to cover the drug at all. Many employer plans exclude weight-management medications as a whole category, separately from the formulary. That exclusion is the thing to check first, before tiers and copays.
The card is capped. Savings are limited — $100 a month on the Novo card, and $100 a month with a $1,300 annual ceiling on the Zepbound card — so a large copay is only partly offset, not erased.
If you have Medicare or Medicaid, savings cards are off the table entirely
Federal rules prohibit manufacturers from offering copay or savings cards to people with government insurance. It applies regardless of income, and no pharmacist can override it. What remains is genuinely different: the Medicare GLP-1 Bridge at $50 a month for eligible Part D enrollees on covered products, Medicare’s Extra Help programme, state pharmaceutical assistance, and manufacturer patient-assistance programmes, which are means-tested and separate from savings cards.
The cost and coverage guide walks the whole insurance pathway, including what to do when a prior authorisation is denied — denials are frequently overturned when the prescriber supplies clinical documentation, and an appeal is usually worth more than switching to a cheaper drug.
Affordable online GLP-1 providers, compared on what you’re billed
We costed 18 published pricing options across the 15 providers in our telehealth directory, adding each company’s membership or programme fee to its medication price to get a monthly total. The comparison sits in the tool above, where you can switch between a steady month, your first month, and year one.
Two findings from doing that arithmetic are worth stating on their own:
11 of the 18 options could be totalled; 7 could not. Not because we didn’t look, but because the provider publishes a membership fee and then does not publish what the medication costs on top of it — or publishes two figures that cannot be reconciled. Those entries carry no total, and the reason is shown in place of a number.
The cheapest headline is rarely the cheapest total. A $79 membership beside a $99 medication is a $178 month. A $19.99 membership with the medication billed separately is not a $19.99 month at all — it is a $19.99 month plus an amount nobody has told you yet.
Why this list is ordered by price, and what that ordering does not mean
Our provider directory is deliberately unranked and alphabetical, because we have not used these services and will not score them. Here the order is by lowest derivable monthly cost — a sort on the one criterion this page is about, chosen by you in the tool, in the same way the match tool sorts only against what you tell it. Cheapest first is not best first. Several of the lowest-priced options carry active litigation flags, and those flags are shown against the price rather than in a footnote.
What “from $99 a month” leaves out
Every advertised price in this category is a real number attached to a narrow condition. The gap between it and your card statement is made of five things, and they stack.
01
The membership, billed separately
The most common structure is a monthly membership for access to a prescriber, plus the medication charged on top. Advertising usually leads with whichever of the two is smaller.
02
The annual prepay behind the lowest rate
Several of the lowest monthly figures are annual-prepay rates. One provider’s $99-a-month compounded semaglutide is $1,188 paid upfront; another’s $74 membership is the twelve-month rate against $149 month-to-month. Ask what the month-to-month price is, and what happens to the prepayment if you stop.
03
The month after the introductory offer
First-month pricing of $25 to $39 is common and is usually a fraction of the standing rate. Budget on month two. In the tool above, the “your first month” view exists precisely so you can see how far apart the two are.
04
The dose you end up on
Doses climb during titration by design — see how titration works for why. Some providers price flat across dose increases and say so; manufacturer self-pay pricing generally does not, with Zepbound published at $299 at the starting dose and $449 higher up. A price quoted at the starting dose is not a price for the year.
05
The units the price is quoted in
A four-week supply is not a calendar month. Thirteen of them fit in a year rather than twelve, which quietly adds a supply’s cost to your annual total without changing the advertised monthly figure at all.
The advertised figure is the first block. The rest is what gets added between the landing page and your card statement.Structural illustration, not to scale — the size of each component differs by provider, and two of them are frequently not published at all.
The price reality check
Eight questions that decide what an advertised price turns into on your card. Open the provider’s own pricing page and tick each one off as you find the answer — if you can’t find it, that is the answer.
Most telehealth pricing has two parts and advertises the smaller one. A $99 medication price beside a $99 membership is a $198 month.
The headline monthly figure is often the annual-prepay rate. Ask what the month-to-month price is, and what happens to the prepayment if you stop.
Introductory first-month offers are common and are usually a fraction of the standing price. Budget on month two, not month one.
Doses climb during titration by design. Some providers price flat across dose increases and some do not — this is the single biggest difference between two apparently identical offers.
A 4-week supply is not a month. Thirteen of them fit in a year, not twelve, which quietly adds a supply's cost to your annual total.
Some programmes bundle labs and coaching into the fee; others bill them separately or do not mention them until you are inside.
Cost over a year depends on how easily you can stop. Find the cancellation terms before you pay, not after.
Compounded semaglutide and tirzepatide are not FDA-approved products and are not reviewed for safety, effectiveness, or manufacturing quality. That is most of the reason they cost less.
0 of 8 answered. Every one of these has a published answer somewhere on a legitimate provider’s site. The ones you can’t find are where the cost hides.
Compounded is cheaper. Here is exactly what you trade for it.
Compounded semaglutide and tirzepatide are the reason the cheap end of this market exists. They are also not the same product as the approved drug, and the difference is not a technicality about branding.
The compounding rules are changing — here's the nuance most sites skip
Compounded semaglutide and tirzepatide became widely available during 2022–2024 while the brand-name versions were on the FDA's drug shortage list, which temporarily let outsourcing facilities compound copies. Semaglutide came off that shortage list in 2025 and tirzepatide in 2024.
On 30 April 2026, the FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the '503B bulks list' — the mechanism that lets large outsourcing facilities compound a drug at scale without an individual prescription in hand. If finalised, this would end large-scale compounded supply from that channel. The proposal's public comment period closed 29 June 2026, and a final decision is still pending as of this writing.
This does not ban compounding outright. Traditional '503A' pharmacies — which compound to fill an individual, patient-specific prescription under state pharmacy board oversight — operate under a separate legal provision and are not directly affected by the 503B proposal. This is why some providers below can still legally offer compounded products even as the bulk-supply channel narrows.
Separately from the shortage rules, Eli Lilly has sued several telehealth companies (see the flags on individual listings below) alleging that some compounded products were marketed deceptively, including undisclosed additives not present in the approved drug. One of those cases (Willow Health) was dismissed in September 2025; the others remained active as of mid-2026. A lawsuit is an allegation, not a finding of fact — but it's a live legal dispute worth knowing about before you buy.
What that means for a price decision: a compounded subscription can be genuinely cheaper per month than a brand-name one, but it is bought outside the FDA approval system, it is not covered by insurance, and the supply channel it depends on may narrow. If you are weighing $178 compounded against $149 for an approved tablet bought direct, the cheaper option is also the approved one — which is not the trade-off this market had two years ago.
There is no over-the-counter GLP-1, and “GLP-1 supplements” are not GLP-1s
A large share of the searching behind this page is for something that does not exist: an over-the-counter GLP-1, a GLP-1 without a prescription, a GLP-1 pill you can buy on a shelf. The honest answer is short. Every FDA-approved GLP-1 receptor agonist is prescription-only. No supplement contains one.
Products marketed as GLP-1 “supplements”, “boosters”, or “activators” are a different category of product entirely. They are not GLP-1 receptor agonists, they are not reviewed before sale the way a drug is, and the comparison to a prescribed medication is a marketing device rather than a clinical one. Whatever they may or may not do, they are not a cheaper version of the thing on this page.
If the price looks impossible, that is the information
Sites that sell GLP-1 products with no medical evaluation are operating outside the regulated supply chain. A legitimate provider evaluates you before prescribing, every time.
“Research chemical” and grey-market peptides are sold with an explicit statement that they are not for human use. That statement is doing legal work, not being modest.
Products sold well below every published price may not be the medication at all. Dosing errors with unlabelled and improperly measured products have caused documented harm.
Verify the pharmacy is licensed before you buy. Our provider directory deliberately excludes sellers that dispense without an evaluation, for exactly this reason.
“GLP-1 near me”: what local access actually changes
Searching locally makes sense for a clinic visit and makes less sense for the price. The medication is dispensed by a pharmacy under national manufacturer pricing or your plan’s terms; a local clinic changes who evaluates you and what that evaluation costs, not what the drug costs. Where locality does matter is availability: compounded products are unavailable in several states, and telehealth providers are licensed state by state, which our directory records provider by provider where each one publishes it.
If you have a regular doctor, that is usually both the cheapest and the best-informed route to a prescription, and it is the one route on this page that costs nothing extra to ask about.
How to keep a cheap price cheap
These medications generally need to be taken long-term to maintain their effect, so the number that matters is not the first month’s price but the twelfth. Four things protect it:
Ask what happens at the next dose. Flat pricing across dose increases is a real feature, and providers that offer it publish it.
Read the cancellation terms before paying for a year. The prepay discount is only a discount if you finish the year.
Re-check your route annually. Formularies change at open enrolment, and a plan that excluded the drug class last year may not this year.
Watch the list price change. Novo Nordisk announced on 24 February 2026 that the list price of Wegovy, Ozempic, and Rybelsus falls to $675 a month from 1 January 2027. Novo Nordisk states the change does not affect direct-to-patient self-pay prices. It matters most if you are paying a coinsurance percentage of the list price rather than a flat copay.
One more, which is a clinical point rather than a financial one: if you stop for cost reasons, appetite generally returns, because the effect depends on the drug being present. That is worth raising with a prescriber before you commit to a price you cannot sustain — see how these medications work.
Questions people ask about cheap GLP-1s
What is the cheapest GLP-1?
The cheapest GLP-1 is decided by who is paying, not by which drug you choose. With commercial insurance that covers the medication, a manufacturer savings card brings it to as little as $25 a month. On Medicare, the GLP-1 Bridge programme is a flat $50 a month for eligible Part D enrollees on covered products. Paying cash, the lowest published price for an FDA-approved product is $149 a month for Wegovy tablets bought direct from NovoCare Pharmacy.
What is the cheapest GLP-1 without insurance?
Buying direct from the manufacturer. NovoCare Pharmacy publishes Wegovy tablets from $149 a month and injection pens from $299 a month; Eli Lilly publishes Zepbound KwikPen self-pay at $299 to $449 a month depending on dose. That is lower than the cheapest telehealth membership plus compounded medication total we were able to derive from published prices, which was about $178 a month. You still need a prescription, which costs whatever your prescriber charges.
Is there an over-the-counter GLP-1?
No. Every FDA-approved GLP-1 receptor agonist is prescription-only, and no over-the-counter product contains one. Products sold as GLP-1 supplements, boosters, or activators are not GLP-1 receptor agonists and are not held to the same standard for what they contain.
Can you get a GLP-1 without a doctor's prescription?
Not legally, and not safely. A prescription requires an evaluation by a licensed clinician, which a legitimate telehealth service will carry out before prescribing. Sites that sell GLP-1 products with no evaluation are operating outside the regulated supply chain, and research-chemical peptide sellers state their products are not intended for human use.
What does a GLP-1 pill cost?
The lowest published self-pay price for an oral GLP-1 is $149 a month for Wegovy tablets from NovoCare Pharmacy, which is also the cheapest published route to any FDA-approved product in the class. Eli Lilly had not published a self-pay price for Foundayo, its orforglipron tablet, as of our last check on 25 July 2026, so we cannot compare it on price.
Why is compounded semaglutide so much cheaper?
Because it is not the FDA-approved product. Compounded semaglutide and tirzepatide are not reviewed by the FDA for safety, effectiveness, or manufacturing quality, and they are not covered by insurance. The FDA proposed in April 2026 to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, which would end large-scale compounded supply from that channel; a final decision was still pending as of August 2026.
Does a cheap telehealth membership include the medication?
Usually not. Most telehealth pricing has two parts — a membership or programme fee and the medication — and the advertised figure is often only one of them. Of the published pricing options we costed across our provider directory, several could not be totalled at all, because the provider publishes a membership fee and then does not publish what the medication costs on top of it.
Are GLP-1 prices about to fall?
One published list price is. Novo Nordisk announced on 24 February 2026 that the list price of Wegovy, Ozempic, and Rybelsus falls to $675 a month from 1 January 2027. The company states this does not change its direct-to-patient self-pay prices, which are already lower than that.
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
Wegovy cost, coverage and savings informationNovoCare, Novo NordiskSupports: NovoCare self-pay pricing for Wegovy tablets and pens and for Ozempic, the $25 savings-card figure and its cap, and the exclusion of government beneficiaries. Verified 25 July 2026.
Zepbound coverage and savingsEli Lilly and CompanySupports: Zepbound self-pay pricing by dose and KwikPen, savings-card caps, and government-insurance exclusions. Verified 25 July 2026.
Medicare GLP-1 Bridge: GLP-1 drugs for $50 a monthMedicare.gov, Centers for Medicare & Medicaid ServicesSupports: The $50 monthly cost, the covered and excluded formulations, eligibility, and the voluntary nature of plan participation.
Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: Prescription-only status of every approved GLP-1 receptor agonist, and the regulatory status of compounded products.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.